LabCompass

Publications

59

Citations

301

Est. group size

Recurring co-author estimate

Active years

12

Publishing since 2015

Research summary
AI-generated

Melissa Lah studies inherited metabolic disorders, focusing on how genetic conditions that affect the body's chemistry can be diagnosed and treated. Much of the work involves clinical trials of therapies for phenylketonuria (PKU), a disorder in which the body cannot properly process the amino acid phenylalanine, along with related rare conditions like homocystinuria and Prader-Willi syndrome. The research spans testing new drugs and enzyme therapies as well as best-practice management guidelines for patients.

Inherited metabolic disordersPhenylketonuria (PKU) therapiesRare genetic disease treatmentClinical trials of drug and enzyme therapiesPrader-Willi syndrome management

Publication activity has grown notably over the last decade, rising from around one to a few papers per year in the late 2010s to roughly nine per year in the most recent five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 9.0/year recently
2017: 1 publication172018: 4 publications18192020: 2 publications202021: 3 publications212022: 10 publications222023: 5 publications232024: 15 publications15242025: 11 publications252026: 4 publications26
Recent publications
Publishes in
  • Molecular Genetics and Metabolism×11
  • Genetics in Medicine Open×7
  • Journal of the Endocrine Society×5
  • Genetics in Medicine×4
  • Value in Health×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile